-
1
-
-
84867163670
-
Molecular pathogenesis of mantle cell lymphoma
-
Jares P, Colomer D, Campo E. Molecular pathogenesis of mantle cell lymphoma. J Clin Invest. 2012; 122(10):3416-3423.
-
(2012)
J Clin Invest
, vol.122
, Issue.10
, pp. 3416-3423
-
-
Jares, P.1
Colomer, D.2
Campo, E.3
-
2
-
-
11144296197
-
How do follicular dendritic cells interact intimately with B cells in the germinal centre?
-
Park CS, Choi YS. How do follicular dendritic cells interact intimately with B cells in the germinal centre? Immunology. 2005;114(1):2-10.
-
(2005)
Immunology
, vol.114
, Issue.1
, pp. 2-10
-
-
Park, C.S.1
Choi, Y.S.2
-
3
-
-
8644252736
-
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
-
Dave SS, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med. 2004; 351(21):2159-2169.
-
(2004)
N Engl J Med
, vol.351
, Issue.21
, pp. 2159-2169
-
-
Dave, S.S.1
-
4
-
-
57149089307
-
Stromal gene signatures in large-B-cell lymphomas
-
Lenz G, et al. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med. 2008;359(22):2313-2323.
-
(2008)
N Engl J Med
, vol.359
, Issue.22
, pp. 2313-2323
-
-
Lenz, G.1
-
6
-
-
32544449329
-
Growth pattern and distribution of follicular dendritic cells in mantle cell lymphoma: A clinicopathological study of 96 patients
-
Schrader C, et al. Growth pattern and distribution of follicular dendritic cells in mantle cell lymphoma: a clinicopathological study of 96 patients. Virchows Arch. 2006;448(2):151-159.
-
(2006)
Virchows Arch
, vol.448
, Issue.2
, pp. 151-159
-
-
Schrader, C.1
-
7
-
-
48149095529
-
MicroRNAs and lymphomas
-
Croce CM. MicroRNAs and lymphomas. Ann Oncol. 2008;19(suppl 4):iv39-iv40.
-
(2008)
Ann Oncol
, vol.19
, Issue.SUPPL. 4
-
-
Croce, C.M.1
-
8
-
-
61349103883
-
MicroRNAs in the ontogeny of leukemias and lymphomas
-
Fabbri M, Croce CM, Calin GA. MicroRNAs in the ontogeny of leukemias and lymphomas. Leuk Lymphoma. 2009;50(2):160-170.
-
(2009)
Leuk Lymphoma
, vol.50
, Issue.2
, pp. 160-170
-
-
Fabbri, M.1
Croce, C.M.2
Calin, G.A.3
-
9
-
-
73649116987
-
The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia
-
Klein U, et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell. 2010; 17(1):28-40.
-
(2010)
Cancer Cell
, vol.17
, Issue.1
, pp. 28-40
-
-
Klein, U.1
-
10
-
-
18744396337
-
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
-
Calin GA, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002;99(24):15524-15529.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, Issue.24
, pp. 15524-15529
-
-
Calin, G.A.1
-
11
-
-
66549101276
-
Patterns of microRNA expression characterize stages of human B-cell differentiation
-
Zhang J, et al. Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood. 2009;113(19):4586-4594.
-
(2009)
Blood
, vol.113
, Issue.19
, pp. 4586-4594
-
-
Zhang, J.1
-
12
-
-
78651285229
-
Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas
-
Lin J, et al. Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas. Leukemia. 2011;25(1):145-152.
-
(2011)
Leukemia
, vol.25
, Issue.1
, pp. 145-152
-
-
Lin, J.1
-
13
-
-
78650056617
-
Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a
-
Lwin T, et al. Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a. Blood. 2010;116(24):5228-5236.
-
(2010)
Blood
, vol.116
, Issue.24
, pp. 5228-5236
-
-
Lwin, T.1
-
14
-
-
0037416151
-
HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo
-
Zhang Y, et al. HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. EMBO J. 2003; 22(5):1168-1179.
-
(2003)
EMBO J
, vol.22
, Issue.5
, pp. 1168-1179
-
-
Zhang, Y.1
-
15
-
-
34248213405
-
HDAC6 deacetylation of tubulin modulates dynamics of cellular adhesions
-
Tran AD, et al. HDAC6 deacetylation of tubulin modulates dynamics of cellular adhesions. J Cell Sci. 2007;120(pt 8):1469-1479.
-
(2007)
J Cell Sci
, vol.120
, Issue.PART 8
, pp. 1469-1479
-
-
Tran, A.D.1
-
16
-
-
58149330694
-
Ubiquitin proteasome system stress underlies synergistic killing of ovarian cancer cells by bortezomib and a novel HDAC6 inhibitor
-
Bazzaro M, et al. Ubiquitin proteasome system stress underlies synergistic killing of ovarian cancer cells by bortezomib and a novel HDAC6 inhibitor. Clin Cancer Res. 2008;14(22):7340-7347.
-
(2008)
Clin Cancer Res
, vol.14
, Issue.22
, pp. 7340-7347
-
-
Bazzaro, M.1
-
17
-
-
0344640906
-
Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation
-
Haggarty SJ, Koeller KM, Wong JC, Grozinger CM, Schreiber SL. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc Natl Acad Sci U S A. 2003;100(8):4389-4394.
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, Issue.8
, pp. 4389-4394
-
-
Haggarty, S.J.1
Koeller, K.M.2
Wong, J.C.3
Grozinger, C.M.4
Schreiber, S.L.5
-
18
-
-
77955355838
-
Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A
-
Butler KV, Kalin J, Brochier C, Vistoli G, Langley B, Kozikowski AP. Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A. J Am Chem Soc. 2010; 132(31):10842-10846.
-
(2010)
J Am Chem Soc
, vol.132
, Issue.31
, pp. 10842-10846
-
-
Butler, K.V.1
Kalin, J.2
Brochier, C.3
Vistoli, G.4
Langley, B.5
Kozikowski, A.P.6
-
19
-
-
79951864878
-
Inhibition of histone deacetylases 1 and 6 enhances cytarabine-induced apoptosis in pediatric acute myeloid leukemia cells
-
Xu X, Xie C, Edwards H, Zhou H, Buck SA, Ge Y. Inhibition of histone deacetylases 1 and 6 enhances cytarabine-induced apoptosis in pediatric acute myeloid leukemia cells. PLoS One. 2011;6(2):e17138.
-
(2011)
PLoS One
, vol.6
, Issue.2
-
-
Xu, X.1
Xie, C.2
Edwards, H.3
Zhou, H.4
Buck, S.A.5
Ge, Y.6
-
20
-
-
84862315462
-
Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas
-
Zhang X, et al. Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas. Oncogene. 2012;31(24):3002-3008.
-
(2012)
Oncogene
, vol.31
, Issue.24
, pp. 3002-3008
-
-
Zhang, X.1
-
21
-
-
84867606040
-
Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-cell lymphomas
-
Zhang X, et al. Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-cell lymphomas. Cancer Cell. 2012;22(4):506-523.
-
(2012)
Cancer Cell
, vol.22
, Issue.4
, pp. 506-523
-
-
Zhang, X.1
-
22
-
-
0033836232
-
Cell cycle activation by c-myc in a burkitt lymphoma model cell line
-
Pajic A, et al. Cell cycle activation by c-myc in a burkitt lymphoma model cell line. Int J Cancer. 2000; 87(6):787-793.
-
(2000)
Int J Cancer
, vol.87
, Issue.6
, pp. 787-793
-
-
Pajic, A.1
-
23
-
-
80052955256
-
BET bromodomain inhibition as a therapeutic strategy to target c-Myc
-
Delmore JE, et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell. 2011; 146(6):904-917.
-
(2011)
Cell
, vol.146
, Issue.6
, pp. 904-917
-
-
Delmore, J.E.1
-
24
-
-
33748302836
-
Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster
-
Dews M, et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet. 2006;38(9):1060-1065.
-
(2006)
Nat Genet
, vol.38
, Issue.9
, pp. 1060-1065
-
-
Dews, M.1
-
25
-
-
2442533725
-
Targeting the bone marrow microenvironment in hematologic malignancies
-
Dalton WS, Hazlehurst L, Shain K, Landowski T, Alsina M. Targeting the bone marrow microenvironment in hematologic malignancies. Semin Hematol. 2004;41(2 suppl 4):1-5.
-
(2004)
Semin Hematol
, vol.41
, Issue.2 SUPPL. 4
, pp. 1-5
-
-
Dalton, W.S.1
Hazlehurst, L.2
Shain, K.3
Landowski, T.4
Alsina, M.5
-
26
-
-
11344293560
-
The biology of human lymphoid malignancies revealed by gene expression profiling
-
Staudt LM, Dave S. The biology of human lymphoid malignancies revealed by gene expression profiling. Adv Immunol. 2005;87:163-208.
-
(2005)
Adv Immunol
, vol.87
, pp. 163-208
-
-
Staudt, L.M.1
Dave, S.2
-
27
-
-
34250788040
-
Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cells
-
Lwin T, et al. Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cells. Leukemia. 2007;21(7):1521-1531.
-
(2007)
Leukemia
, vol.21
, Issue.7
, pp. 1521-1531
-
-
Lwin, T.1
-
28
-
-
58249102301
-
Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis
-
Lwin T, et al. Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis. Leukemia. 2009;23(1):170-177.
-
(2009)
Leukemia
, vol.23
, Issue.1
, pp. 170-177
-
-
Lwin, T.1
-
29
-
-
84873332932
-
Sorafenib inhibits cell migration and stroma-mediated bortezomib resistance by interfering B-cell receptor signaling and protein translation in mantle cell lymphoma
-
Xargay-Torrent S, et al. Sorafenib inhibits cell migration and stroma-mediated bortezomib resistance by interfering B-cell receptor signaling and protein translation in mantle cell lymphoma. Clin Cancer Res. 2013;19(3):586-597.
-
(2013)
Clin Cancer Res
, vol.19
, Issue.3
, pp. 586-597
-
-
Xargay-Torrent, S.1
-
30
-
-
69249087671
-
Environmentmediated drug resistance: A major contributor to minimal residual disease
-
Meads MB, Gatenby RA, Dalton WS. Environmentmediated drug resistance: a major contributor to minimal residual disease. Nat Rev Cancer. 2009; 9(9):665-674.
-
(2009)
Nat Rev Cancer
, vol.9
, Issue.9
, pp. 665-674
-
-
Meads, M.B.1
Gatenby, R.A.2
Dalton, W.S.3
-
31
-
-
65549122964
-
Acetylation of FoxO1 activates Bim expression to induce apoptosis in response to histone deacetylase inhibitor depsipeptide treatment
-
Yang Y, et al. Acetylation of FoxO1 activates Bim expression to induce apoptosis in response to histone deacetylase inhibitor depsipeptide treatment. Neoplasia. 2009;11(4):313-324.
-
(2009)
Neoplasia
, vol.11
, Issue.4
, pp. 313-324
-
-
Yang, Y.1
-
32
-
-
52649133274
-
HDAC6 inhibition enhances 17-AAG-mediated abrogation of hsp90 chaperone function in human leukemia cells
-
Rao R, et al. HDAC6 inhibition enhances 17-AAG-mediated abrogation of hsp90 chaperone function in human leukemia cells. Blood. 2008;112(5):1886-1893.
-
(2008)
Blood
, vol.112
, Issue.5
, pp. 1886-1893
-
-
Rao, R.1
-
33
-
-
22844432021
-
Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: A novel basis for antileukemia activity of histone deacetylase inhibitors
-
Bali P, et al. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors. J Biol Chem. 2005;90(29):26729-26734.
-
(2005)
J Biol Chem
, vol.90
, Issue.29
, pp. 26729-26734
-
-
Bali, P.1
-
34
-
-
21144444486
-
HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor
-
Kovacs JJ, et al. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol Cell. 2005;18(5):601-607.
-
(2005)
Mol Cell
, vol.18
, Issue.5
, pp. 601-607
-
-
Kovacs, J.J.1
-
35
-
-
79954535049
-
Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer
-
Park SY, et al. Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer. Oncol Rep. 2011; 25(6):1677-1681.
-
(2011)
Oncol Rep
, vol.25
, Issue.6
, pp. 1677-1681
-
-
Park, S.Y.1
-
36
-
-
54749101159
-
The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis
-
Lee YS, et al. The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis. Cancer Res. 2008;68(18):7561-7569.
-
(2008)
Cancer Res
, vol.68
, Issue.18
, pp. 7561-7569
-
-
Lee, Y.S.1
-
37
-
-
71949117093
-
Bim upregulation by histone deacetylase inhibitors mediates interactions with the Bcl-2 antagonist ABT-737: Evidence for distinct roles for Bcl-2, Bcl-xL, and Mcl-1
-
Chen S, Dai Y, Pei XY, Grant S. Bim upregulation by histone deacetylase inhibitors mediates interactions with the Bcl-2 antagonist ABT-737: evidence for distinct roles for Bcl-2, Bcl-xL, and Mcl-1. Mol Cell Biol. 2009;29(23):6149-6169.
-
(2009)
Mol Cell Biol
, vol.29
, Issue.23
, pp. 6149-6169
-
-
Chen, S.1
Dai, Y.2
Pei, X.Y.3
Grant, S.4
-
38
-
-
33845352223
-
Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells
-
Gillespie S, Borrow J, Zhang XD, Hersey P. Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells. Apoptosis. 2006;11(12):2251-2265.
-
(2006)
Apoptosis
, vol.11
, Issue.12
, pp. 2251-2265
-
-
Gillespie, S.1
Borrow, J.2
Zhang, X.D.3
Hersey, P.4
-
39
-
-
77951685547
-
The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells
-
Mandl-Weber S, Meinel FG, Jankowsky R, Oduncu F, Schmidmaier R, Baumann P. The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells. Br J Haematol. 2010;149(4):518-528.
-
(2010)
Br J Haematol
, vol.149
, Issue.4
, pp. 518-528
-
-
Mandl-Weber, S.1
Meinel, F.G.2
Jankowsky, R.3
Oduncu, F.4
Schmidmaier, R.5
Baumann, P.6
-
40
-
-
34249993174
-
SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib
-
Emanuele S, et al. SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib. Apoptosis. 2007; 12(7):1327-1338.
-
(2007)
Apoptosis
, vol.12
, Issue.7
, pp. 1327-1338
-
-
Emanuele, S.1
-
41
-
-
2342564962
-
Histone deacetylase inhibitors FK228 N-(2-aminophenyl)-4-[N-(pyridin-3- yl-methoxycarbonyl) amino-methyl]benzamide and m-carboxycinnamic acid bis-hydroxamide augment radiation-induced cell death in gastrointestinal adenocarcinoma cells
-
Zhang Y, Adachi M, Zhao X, Kawamura R, Imai K. Histone deacetylase inhibitors FK228, N-(2-aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl) amino-methyl]benzamide and m-carboxycinnamic acid bis-hydroxamide augment radiation-induced cell death in gastrointestinal adenocarcinoma cells. Int J Cancer. 2004;110(2):301-308.
-
(2004)
Int J Cancer
, vol.110
, Issue.2
, pp. 301-308
-
-
Zhang, Y.1
Adachi, M.2
Zhao, X.3
Kawamura, R.4
Imai, K.5
-
42
-
-
84857923137
-
MicroRNA miR-548d is a superior regulator in pancreatic cancer
-
Heyn H, Schreek S, Buurman R, Focken T, Schlegelberger B, Beger C. MicroRNA miR-548d is a superior regulator in pancreatic cancer. Pancreas. 2012; 41(2):218-221.
-
(2012)
Pancreas
, vol.41
, Issue.2
, pp. 218-221
-
-
Heyn, H.1
Schreek, S.2
Buurman, R.3
Focken, T.4
Schlegelberger, B.5
Beger, C.6
-
43
-
-
37549008310
-
Widespread microRNA repression by Myc contributes to tumorigenesis
-
Chang TC, et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet. 2008;40(1):43-50.
-
(2008)
Nat Genet
, vol.40
, Issue.1
, pp. 43-50
-
-
Chang, T.C.1
-
44
-
-
64749116346
-
C-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
-
Gao P, et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature. 2009; 458(7239):762-765.
-
(2009)
Nature
, vol.458
, Issue.7239
, pp. 762-765
-
-
Gao, P.1
-
45
-
-
84865790633
-
The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas
-
Di Lisio L, Martinez N, Montes-Moreno S, Piris-Villaespesa M, Sanchez-Beato M, Piris MA. The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas. Blood. 2012;120(9):1782-1790.
-
(2012)
Blood
, vol.120
, Issue.9
, pp. 1782-1790
-
-
Di Lisio, L.1
Martinez, N.2
Montes-Moreno, S.3
Piris-Villaespesa, M.4
Sanchez-Beato, M.5
Piris, M.A.6
-
46
-
-
34547137412
-
Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantlecell and other non-Hodgkin B-cell lymphomas
-
Lwin T, et al. Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantlecell and other non-Hodgkin B-cell lymphomas. Blood. 2007;110(5):1631-1638.
-
(2007)
Blood
, vol.110
, Issue.5
, pp. 1631-1638
-
-
Lwin, T.1
|